Abstract #2209
MRS of Basal-Ganglia in Parkinsons Disease Reveals Higher GABA Levels
Shalmali Dharmadhikari 1,2 , Ruoyun Ma 1,2 , Chien- Lin Yeh 1,2 , Sandy Snyder 1 , S E Zauber 3 , and Ulrike Dydak 1,2
1
School of Health Sciences, Purdue
University, W Lafayette, IN, United States,
2
Department
of Radiology and Imaging Sciences, Indiana University
School of Medicine, Indianapolis, IN, United States,
3
Department
of Neurology, Indiana University School of Medicine,
Indianapolis, IN, United States
Gamma-aminobutyric acid (GABA) is an important
inhibitory neurotransmitter of the basal ganglia, which
is hypothesized to be altered in Parkinsons disease
(PD). Our aim was to evaluate the use of GABA MRS for
understanding these alterations and their relation to
disease severity, while reducing influence of PD
medicines. GABA MRS in PD patients, who were temporarily
withheld medication, revealed elevated GABA levels in
the thalamus, which were also associated with disease
severity as measured clinically by motor scores. Thus
GABA MRS confirms the role of GABA in PD and has a
potential to be used a non-invasive biomarker of PD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
